Condition
Cholangiocarcinoma, Intrahepatic clinical trials and research
Research outlook What's coming for Cholangiocarcinoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Cholangiocarcinoma, Intrahepatic clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
CD160-Enhanced Autologous T Cells for Advanced Biliary Tract Cancer
This trial tests a patient‑made T cell therapy (BTC-Ag-T) to see if it is safe and can help people with advanced biliary tract cancer who have exhausted standard treatments.
-
Liver transplantation for patients with advanced intrahepatic cholangiocarcinoma
This study is testing if liver transplantation can help patients with advanced bile duct cancer live longer after they’ve had treatment, compared to those who only received chemotherapy.
Related topics
Quick answers
How many Cholangiocarcinoma, Intrahepatic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.